- Report
- August 2025
- 184 Pages
Global
From €3496EUR$3,939USD£3,009GBP
- Report
- August 2025
- 197 Pages
Global
From €3147EUR$3,545USD£2,708GBP
€3496EUR$3,939USD£3,009GBP
- Report
- August 2025
- 375 Pages
Global
From €5193EUR$5,850USD£4,469GBP
Cloxacillin is an antibiotic drug belonging to the penicillin family. It is used to treat a variety of bacterial infections, including skin and soft tissue infections, bone and joint infections, and respiratory tract infections. Cloxacillin is also used to prevent infections in people who are at risk of developing them, such as those undergoing surgery or chemotherapy. Cloxacillin is available in both oral and injectable forms.
Cloxacillin is a widely used antibiotic, and is often prescribed as a first-line treatment for bacterial infections. It is generally well tolerated, with few side effects. However, it is not effective against certain types of bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA).
The cloxacillin market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more